Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IO Biotech, Inc.

IO Biotech, Inc. (IOBT) Stock Overview

Explore IO Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IOBT●NASDAQ
HealthcareBiotechnology
$0.01
$0.005(27.59%)
U.S. Market opens in 35h 43m

IO Biotech, Inc. (IOBT)

Meyka AI Score

Z

Key Financials

Market Cap885.7K
P/E Ratio-0.01
EPS (TTM)$-0.23
ROE-5.91%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

IOBT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IO Biotech, Inc. (NASDAQ: IOBT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, IO Biotech, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IOBT on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind IO Biotech, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.01 and a market capitalization of 885.7K. Combined with our AI analysis, these give both institutional and retail investors a clear view of IOBT on the NASDAQ.

Price Performance (NASDAQ: IOBT)

1-Day Change
207.75%
5-Day Change
115.96%
1-Month Change
N/A
3-Month Change
-96.70%
6-Month Change
-98.63%
Year-to-Date (YTD) Change
-97.98%
1-Year Change
-98.77%
3-Year Change
-99.40%
5-Year Change
-99.92%
All-Time (Max) Change
-99.92%

Contact Information

https://www.iobiotech.com
45 70 70 29 80
Ole Maaløes Vej 3, Copenhagen, NaN, 2200

Company Facts

800 Employees
IPO DateNov 5, 2021
CountryDK

Frequently Asked Questions